These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 7200363

  • 1. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P, Hall MD, Murugaiah K, Rupniak N, Theodorou A, Marsden CD.
    Biochem Pharmacol; 1982 Feb 01; 31(3):325-8. PubMed ID: 7200363
    [Abstract] [Full Text] [Related]

  • 2. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Feb 01; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 3. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 4. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P, Rupniak NM, Marsden CD.
    Psychopharmacology Suppl; 1985 Oct 01; 2():174-81. PubMed ID: 3159009
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Oct 01; 84(4):503-11. PubMed ID: 6441951
    [Abstract] [Full Text] [Related]

  • 6. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P, Rupniak NM, Hall MD, Dyer R, Leigh N, Marsden CD.
    Eur J Pharmacol; 1981 Nov 19; 76(1):31-6. PubMed ID: 6119220
    [Abstract] [Full Text] [Related]

  • 7. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1980 May 02; 63(2-3):145-57. PubMed ID: 6103814
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N, Dall'Olio R, Gandolfi O, Vaccheri A.
    Eur J Pharmacol; 1982 Jun 16; 81(1):1-9. PubMed ID: 6889533
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May 16; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.